CytoMed Therapeutics (GDTC) Earnings (2020 - 2025)
CytoMed Therapeutics (GDTC) earnings from Mar 31, 2020 to Dec 31, 2025. The TTM CytoMed Therapeutics (GDTC) earnings is -$3.74M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
CytoMed Therapeutics (GDTC) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +110.32% |
| 3 Years TTM | +7.85% |
| 5 Years TTM | +21.40% |
| All Time TTM | +19.44% |
Annual Earnings change of CytoMed Therapeutics (GDTC)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$3.05M | +61.95% |
| 2024 | -$1.88M | -40.00% |
| 2023 | -$3.14M | +37.42% |
| 2022 | -$2.28M | +48.76% |
| 2021 | -$1.54M | +4.52% |
| 2020 | -$1.47M | +129.87% |
| 2019 | -$639K | N/A |